OLMESARTAN +AMLOIPINE TREATMENT IN DIABETIC PATIENTS: EVALUATING BLOOD PRESSURE CONTROL AFTER 48 HOURS FROM THE LAST ADMINISTRATION (MISSED DOSE).
Phase of Trial: Phase III
Latest Information Update: 24 May 2016
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary) ; Perindopril/amlodipine
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Acronyms OLMAML
- Sponsors Menarini
- 24 May 2016 Results (post hoc analysis of a substudy) comparing effect of olmesartan/amlodipine versus perindopril/amlodipine published in the American Journal of Hypertension.
- 15 Jun 2015 Primary endpoint Office diastolic blood pressure has been met as per results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.